Clinical Trial Update: Polymeric Micellar Paclitaxel for Metastatic Pancreatic Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating polymeric micellar paclitaxel for metastatic pancreatic cancer. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Polymeric micellar paclitaxel (paclitaxel)

Snippet

Sponsor: Shanghai Yizhong Pharmaceutical Co., Ltd. | Conditions: Pancreatic Cancer Metastatic | Phase 3 | Status: RECRUITING